SOD1 and amyotrophic lateral sclerosis: As previously described, neuromuscular defects are apparent in ALS rodent models and patients well before symptom onset and MN loss [3,4]; therefore, we next performed a detailed pathological characterization of NMJs and MNs in control and transgenic G93A-SOD1-GFP zebrafish.